KING OF PRUSSIA, PA — Vertex Inc. (Nasdaq: VERX) said Tuesday its Vertex O Series Tax Engine and Indirect Tax Accelerator for ...

Vertex Pharmaceuticals will soon try to commercialize another medicine. The new therapy targets the same market as four of its other products. Using a priority review voucher is an expensive choice, ...

Total revenues of $666.8 million for the full year 2024, representing a 16.5% year-over-year increase, indicating strong business growth. Cloud revenues grew by 28.6% year-over-year for the full year ...

Google announced today that its generative AI support in Vertex AI, the company’s machine learning platform, is now generally available. Based on Google’s models like PaLM 2, Imagen and Codey, Vertex ...

👉 Learn how to identify the vertex of a parabola by completing the square. A parabola is the shape of the graph of a ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs), today announced a global, multi-target license and option agreement ...

On Tuesday, 03 March 2026, Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) presented at the TD Cowen 46th Annual Health Care Conference, outlining its strategic vision and pipeline progress. CEO Reshma ...

— Full year total revenue of $12.0 billion, a 9% increase compared to full year 2024; fourth quarter total revenue of $3.19 billion, a 10% increase compared to fourth quarter 2024 — — Company provides ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for controversial ...